Latest

PRESS RELEASE Americans for Safe Access For Immediate Release: November 10, 2009 AMA Report Recognizes Medical Benefits of Marijuana, Urges Further Research Largest and oldest U.S. physician-based group reverses long-held position on medical marijuana Houston, TX -- The American Medical Association (AMA) voted today to reverse its long-held position that marijuana be retained as a Schedule I substance with no medical value. The AMA adopted a report drafted by the AMA Council on Science and Public Health (CSAPH) entitled, "Use of Cannabis for Medicinal Purposes," which affirmed the therapeutic benefits of marijuana and called for further research. The CSAPH report concluded that, "short term controlled trials indicate that smoked cannabis reduces neuropathic pain, improves appetite and caloric intake especially in patients with reduced muscle mass, and may relieve spasticity and pain in patients with multiple sclerosis." Furthermore, the report urges that "the Schedule I status of marijuana be reviewed with the goal of facilitating clinical research and development of cannabinoid-based medicines, and alternate delivery methods." The change of position by the largest physician-based group in the country was precipitated in part by a resolution adopted in June of 2008 by the Medical Student Section (MSS) of the AMA in support of the reclassification of marijuana's status as a Schedule I substance. In the past year, the AMA has considered three resolutions dealing with medical marijuana, which also helped to influence the report and its recommendations. The AMA vote on the report took place in Houston, Texas during the organization's annual Interim Meeting of the House of Delegates. The last AMA position, adopted 8 years ago, called for maintaining marijuana as a Schedule I substance, with no medical value. "It's been 72 years since the AMA has officially recognized that marijuana has both already-demonstrated and future-promising medical utility," said Sunil Aggarwal, Ph.D., the medical student who spearheaded both the passage of the June 2008 resolution by the MSS and one of the CSAPH report's designated expert reviewers. "The AMA has written an extensive, well-documented, evidence-based report that they are seeking to publish in a peer-reviewed journal that will help to educate the medical community about the scientific basis of botanical cannabis-based medicines." Aggarwal is also on the Medical & Scientific Advisory Board of Americans for Safe Access (ASA), the largest medical marijuana advocacy organization in the U.S. The AMA's about face on medical marijuana follows an announcement by the Obama Administration in October discouraging U.S. Attorneys from taking enforcement actions in medical marijuana states. In February 2008, a resolution was adopted by the American College of Physicians (ACP), the country's second largest physician group and the largest organization of doctors of internal medicine. The ACP resolution called for an "evidence-based review of marijuana's status as a Schedule I controlled substance to determine whether it should be reclassified to a different schedule. "The two largest physician groups in the U.S. have established medical marijuana as a health care issue that must be addressed," said ASA Government Affairs Director Caren Woodson. "Both organizations have underscored the need for change by placing patients above politics." Though the CSAPH report has not been officially released to the public, AMA documentation indicates that it: "(1) provides a brief historical perspective on the use of cannabis as medicine; (2) examines the current federal and state-based legal envelope relevant to the medical use of cannabis; (3) provides a brief overview of our current understanding of the pharmacology and physiology of the endocannabinoid system; (4) reviews clinical trials on the relative safety and efficacy of smoked cannabis and botanical-based products; and (5) places this information in perspective with respect to the current drug regulatory framework." Further information: Executive Summary of AMA Report: http://AmericansForSafeAccess.org/downloads/AMA_Report_Executive_Summary.pdf Recommendations of AMA Report: http://AmericansForSafeAccess.org/downloads/AMA_Report_Recommendations.pdf American College of Physicians resolution: http://www.acponline.org/advocacy/where_we_stand/other_issues/medmarijuana.p df # # # With over 30,000 active members in more than 40 states, Americans for Safe Access (ASA) is the largest national member-based organization of patients, medical professionals, scientists and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research. ASA works to overcome political and legal barriers by creating policies that improve access to medical cannabis for patients and researchers through legislation, education, litigation, grassroots actions, advocacy and services for patients and the caregivers.

FOR IMMEDIATE RELEASE: November 5, 2009 CONTACT: Tony Newman at 646-335-5384 or Tommy McDonald at 636-335-2242 Montel Williams, Celebrated Talk Show Host and Medical Marijuana Patient/Advocate, to Receive Award at International Drug Policy Reform Conference in New Mexico Award Recognizes Williams' Pioneering Advocacy for Compassionate Drug Laws and Safe Access to Medical Marijuana Montel Williams, veteran TV talk show host and currently the host of Montel Across America, a nationally syndicated daily radio show, will receive the The Edward M. Brecher Award for Achievement in the Field of Journalism at the International Drug Policy Reform Conference in Albuquerque, New Mexico on Nov. 13, 2009. Williams, who suffers from multiple sclerosis and uses medical marijuana to relieve chronic nerve pain, is being honored by the Drug Policy Alliance for his groundbreaking journalism and outspoken advocacy on behalf of medical marijuana patients and providers. Williams will accept the award during the conference awards dinner, which begins at 7:30 p.m. at the Hyatt Regency Albuquerque. Since going public with his personal medical marijuana use in late 2003, Williams has tirelessly campaigned for changes in state and federal laws to expand access to marijuana as a medicine. In addition to writing Climbing Higher, his 2004 autobiography that detailed his struggle with MS and the therapeutic effects of cannabis, Williams has hosted TV shows on the topic of medical marijuana, authored Op-Ed pieces in major newspapers and used his platform as a public figure to press legislators across the country to enact new drug policies based on compassion, reason and science. In particular, Williams traveled to state capitals in Albany, NY and Trenton, NJ, as well as Washington, D.C., to urge elected officials to pass medical marijuana legislation. "I utilize medical marijuana to help alleviate the extreme neuralgic pain I suffer from," said Montel Williams. "I am not alone. There are thousands of patients like me, and we should not be treated as criminals." “Montel is in a league of his own insofar as the effort to legalize medical marijuana is concerned,” said Ethan Nadelmann, executive director of the Drug Policy Alliance. “No one has used his media pulpit as effectively and passionately as he has in combating drug war intransigence.” The Drug Policy Alliance, the nation's leading organization promoting policy alternatives to the drug war, bestows the biennial Edward M. Brecher Award to media figures who show the courage and leadership to question official drug war propaganda. Previous recipients include: ABC News Anchor Hugh Downs; Cartoonist Gary Trudeau; The Economist magazine; Rolling Stone magazine; William Finnegan, staff writer for The New Yorker; and Eric Schlosser, author of Fast Food Nation and Reefer Madness, among other distinguished honorees. The International Drug Policy Reform Conference, co-hosted by the Drug Policy Alliance in Albuquerque, NM from Nov. 12-14, 2009, brings together nearly 1000 leading international experts, treatment providers, researchers, policymakers and key activists at the leading global forum on drug policy reform. For more information or to register for the conference, please visit www.reformconference.org. To purchase tickets for the awards ceremony: http://www.regonline.com/Checkin.asp?EventId=784745.

FOR IMMEDIATE RELEASE: November 5, 2009 CONTACT: Tony Newman at 646-335-5384 NY State Assemblyman Jeffrion L. Aubry, Chief Sponsor of Historic Rockefeller Drug Law Reform Legislation, to Receive Award at International Drug Policy Reform Conference in New Mexico Award Recognizes Aubry's Leadership and Tenacity in Successful Effort to Roll Back Draconian New York State Drug Laws New York State Assemblyman Jeffrion L. Aubry, a longtime champion of efforts to reform New York's harsh Rockefeller Drug Laws, will receive the Justice Gerald Le Dain Award for Achievement in the Field of Law at the International Drug Policy Reform Conference in Albuquerque, New Mexico on Nov. 13, 2009. Aubry, who introduced bills to repeal New York's mandatory drug sentencing laws in every legislative session since 1997, is being honored by the Drug Policy Alliance for his unyielding commitment to reform culminating in this year's passage of sweeping changes to the Rockefeller laws. The Justice Gerald Le Dain Award for Achievement in the Field of La is bestowed on those involved in the law who work within official institutions to challenge traditional drug war orthodoxy. Previous recipients include: Congressman John Conyers, Jr. (D-MI); federal judges Robert Sweet (NY) and John Kane (Denver); former police chiefs Joseph D. McNamara ( Kansas City and San Jose) and Nicholas Pastore (New Haven, CT); Canadian Member of Parliament Libby Davies; and other distinguished attorneys, activists, judges and others. Aubry, chair of the Assembly Standing Committee on Correction, led the successful fight to repeal mandatory minimum sentences for most low-level, nonviolent drug offenses in New York and instead return discretion to judges to determine whether to divert individuals to treatment or probation instead of incarceration. The reforms, signed into law in April by New York Gov. David Paterson and enacted in October, signal a shift toward treating drug use as public health issue rather a criminal justice matter. "Thirty-five years of a drug policy focused on punishing drug users and spending billions of dollars on incarceration has failed to reduce drug use or drug-related crime," Aubry said. "Unfortunately, we have spent hundreds of millions of dollars locking up individuals, mostly African-Americans and Latinos, with drug abuse problems rather than offering them needed drug treatment. This historic reform enacts a sensible, comprehensive and cost-effective approach for dealing with nonviolent drug offenders and will ensure that drug abusers are able to access effective substance abuse treatment and counseling." Aubry has represented the 35th Assembly District in Queens since 1992. He previously served as Director of Economic Development for the Borough President's Office of Queens. For 16 years, he worked in the drug treatment program at Elmcor Youth and Adult Activities, one of the largest nonprofit social service agencies in Queens. Ethan Nadelmann, executive director of the Drug Policy Alliance, said, “I don’t know of any state legislator in the country who has fought so long, so hard, and now so successfully to reform a drug war injustice as Jeff Aubry.” The International Drug Policy Reform Conference, co-hosted by the Drug Policy Alliance in Albuquerque, NM from Nov. 12-14, 2009, is the outstanding gathering in the world of people working to reform local, national and foreign drug policies. For more information or to register for the conference, please visit www.reformconference.org. To purchase tickets for the awards ceremony: http://www.regonline.com/Checkin.asp?EventId=784745.